Participants 76 163 4
deceased-donor kidney transplant recipients at specified risk of delayed graft function
Participants 580 655 7
Deceased-donor kidney transplant patients at protocol-specified risk of DGF
Participants 1290 1396 3
lar between groups. Adverse events led to study drug discontinuation in 17â€ƒIE patients (26.2%) and 28 DE
